Association of adenovirus 36 infection and obesity; An updated meta-analysis of community-based studies

Rev Med Virol. 2022 Jan;32(1):e2255. doi: 10.1002/rmv.2255. Epub 2021 May 24.

Abstract

As a health problem, obesity has several risk factors; it has been suggested that human adenovirus type 36 (HAdV-36) infections may possibly be associated with obesity. This updated meta-analysis was designed and conducted with an emphasis on articles published from 2015 to 2020. The PubMed, Web of Science, and Scopus databases were searched up to 1 December 2020. Overall, pooled prevalence and odds ratio of antibodies against HAdV-36 in people with obesity and controls was assessed among different ages. Case-control and cohort studies were included in the analysis. The overall prevalence of HAdV-36 infection in obese population was 31% (CI: 0.24%-0.38%) which was 32% in cases and 27% in controls, respectively; a significant association was found between the cases and the controls (OR, 1.84; 95% CI, 1.39-2.43), especially in children younger than 18 years of age (OR, 2.44; 95% CI, 1.85-3.22). A significant association between adenovirus infection and obesity was found, especially in adolescents.

Keywords: human adenovirus type 36; meta-analysis; obesity.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Adenoviridae Infections* / complications
  • Adenoviridae Infections* / epidemiology
  • Adenoviruses, Human*
  • Adolescent
  • Case-Control Studies
  • Child
  • Humans
  • Obesity / complications
  • Obesity / epidemiology
  • Odds Ratio